Every six minutes, someone in the United States is diagnosed with melanoma, which is the deadliest form of skin cancer. It strikes people from all walks of life, and if it isn’t treated promptly, it can spread to other parts of the body.
Signs of Melanoma
However, if melanoma is treated in its early stages, prognosis is very good. That’s why you should know the signs:
- A new spot on your skin, mole or growth that doesn’t look like your other moles.
- Changes in the shape, color or size of an existing mole.
- A sore that won’t heal.
Higher Risk Areas
Melanoma can occur in various parts of the body, including the liver, mouth, eyes, colon and vagina. You may be at a higher risk of melanoma if you have:
- A family history of melanoma or unusual moles.
- Fair skin.
- A history of blistering sunburns.
Learn more about melanoma, including treatment and clinical trial info, at the Holden Comprehensive Cancer Center.
Dr. Mohammed Milhem & the Holden Comprehensive Cancer Center
Tad’s oncologist, Dr. Mohammed Milhem, known to all his patients as Dr. Mo, specializes in hematology, oncology and blood and marrow transplantation at the University of Iowa Health Care’s Carver College of Medicine. He’s also the Holden Family Chair for Experimental Therapeutics and previously served as the co-leader of the Experimental Therapeutics program at the Holden Comprehensive Cancer Center. As the Holden Chair, Milhem oversees the Comprehensive Cancer Center’s investigator-initiated trial portfolio, and he mentors junior faculty in clinical trial development.
Money raised by the Tad Agnew Foundation largely benefits Holden’s Melanoma Department, as well as Dr. Mo’s team conducting research and running multiple clinical trials. Learn more about melanoma, including treatment and clinical trial info, at the Holden Comprehensive Cancer Center.
Want to get involved?
Would you like to support the Tad Agnew Foundation and melanoma research? Learn more about how you can get involved and support melanoma research.